FORTAZ is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Teligent Pharma, Inc.. The primary component is Ceftazidime.
Product ID | 52565-113_da2c70ba-ae63-494a-88d7-082b32ab4f7c |
NDC | 52565-113 |
Product Type | Human Prescription Drug |
Proprietary Name | FORTAZ |
Generic Name | Ceftazidime Sodium |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2013-04-15 |
Marketing Category | NDA / NDA |
Application Number | NDA050634 |
Labeler Name | Teligent Pharma, Inc. |
Substance Name | CEFTAZIDIME |
Active Ingredient Strength | 40 mg/mL |
Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-10-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050634 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-10-19 |
Marketing End Date | 2019-09-12 |
Ingredient | Strength |
---|---|
CEFTAZIDIME | 40 mg/mL |
SPL SET ID: | 78982c98-7866-49f1-989f-a289c4242358 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
52565-105 | FORTAZ | ceftazidime |
52565-106 | FORTAZ | ceftazidime |
52565-107 | FORTAZ | ceftazidime |
52565-109 | FORTAZ | ceftazidime |
52565-110 | FORTAZ | ceftazidime |
52565-111 | FORTAZ | ceftazidime |
52565-112 | FORTAZ | ceftazidime sodium |
52565-113 | FORTAZ | ceftazidime sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FORTAZ 73376990 1286762 Live/Registered |
Glaxo Group Limited 1982-07-28 |